Clinical Trials for Drug: Pembrolizumab

4 Open Trials. Phone:(877.827.8839)
Protocol No. Title Status
SWOG-S1418 A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with > 1 cm Residual Invasive Cancer or Positive Lymph Nodes (>pN1mic) After Neoadjuvant Chemotherapy Open
UCI-14-95 A Phase I/II Study of the Blinatumomab in Combination with the PD-1 Inhibitor Pembrolizumab (MK-3475) for the Treatment of Adults with Relapsed or Refractory B-Lineage Acute Lymphoblastic Leukemia Open
UCI-16-76 Phase Ib/II Trial of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (mCRPC) (KEYNOTE-365) Open
UCI-16-94 Phase IIA Single-Arm Study of Treatment of Patients with Advanced Liver Cancer with a Combination of TATE (Transarterial Tirapazamine Embolization) Followed by an Anti- PD-1 Monoclonal Antibody Open